Trevi Therapeutics TRVI
NASDAQ TRVI
$12.56 -0.38 (-2.90%)
As of: Oct 23, 2026 · 2:43 PM EDT

Trevi Therapeutics (TRVI) Return on Sales [ROS] (2018 - 2024)

Updated

Analysis

Trevi Therapeutics (TRVI) Return on Sales [ROS] (2018 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,124.12 Bn 1,092.71 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 634.38 Bn 554.24 Bn 17.30 Bn 24.35%
3 AbbVie 505.39 Bn 478.50 Bn 12.70 Bn 37.86%
4 Merck 357.36 Bn 311.74 Bn 12.21 Bn -3.52%
5 Novartis Ag 290.21 Bn 254.20 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.21 Bn 238.89 Bn 12.86 Bn 20.57%
7 Amgen 237.81 Bn 193.21 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -133.21%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 28.37%
10 Trevi Therapeutics 1.97 Bn 1.10 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -1,321.93%
Mar 31, 2024 -1,093.19%
Dec 31, 2023 -686.28%
Sep 30, 2023 -651.82%
Jun 30, 2023 -594.45%
Mar 31, 2023 -524.82%
Dec 31, 2022 -595.97%
Sep 30, 2022 -1,982.31%
Jun 30, 2022 -4,010.26%
Mar 31, 2022 -175,625.00%
Dec 31, 2021 -275,766.67%
Sep 30, 2021 -347,350.00%
Jun 30, 2021 -458,350.00%
Mar 31, 2021 -269,633.33%
Dec 31, 2020 -229,825.00%
Sep 30, 2020 -241,466.67%
Jun 30, 2020 -52,950.00%
Mar 31, 2020 -5,502.55%
Dec 31, 2019 -3,007.11%
Sep 30, 2019 -2,732.14%
API Access

Trevi Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TRVI&period=max&api_key=YOUR_API_KEY